EMEM

Sophus Capital Emerging Market ETF

International / EmergingNASDAQ-GMARK ETF
$25.84
- (-0.12%)
Real-time · Sep 1, 2026 7:50 PM ET

Key Statistics

Net Assets (AUM)
$61.07M
Expense Ratio
See prospectus
Previous Close
$25.97
Day Range
$25.79 – $26.08
52-Week Range
$23.41 – $28.66
Volume
4.83K
Avg Vol (50D)
-
Beta
2.22

Historical Performance

1M
+4.97%
3M
-5.84%
6M
YTD
1Y
+2.60%
3Y
5Y

Total return including reinvested distributions, from adjusted closing prices.

Price History

Price history is being compiled for this fund.

Top Holdings

TSM Taiwan Semiconductor Manufacturing Co Ltd 16.70%
005930 KS Samsung Electronics Co Ltd 9.58%
000660 KS SK hynix Inc 5.15%
TCEHY Tencent Holdings Ltd 3.72%
2454 TT MediaTek Inc 1.91%
FGXXX First American Government Obligations Fund 1.62%
2308 TT Delta Electronics Inc 1.57%
ITUB Itau Unibanco Holding SA 1.42%
2327 TT Yageo Corp 1.40%
SHFL IN Shriram Finance Ltd 1.31%
3968 HK China Merchants Bank Co Ltd 1.30%
2303 TT United Microelectronics Corp 1.29%
PBR Petroleo Brasileiro SA - Petrobras 1.19%
2059 TT King Slide Works Co Ltd 1.16%
3017 TT Asia Vital Components Co Ltd 1.12%
BOMH IN Bank of Maharashtra 1.10%
ALINMA AB Alinma Bank 1.08%
5536 TT Acter Group Corp Ltd 1.04%
6669 TT Wiwynn Corp 1.03%
MUTH IN Muthoot Finance Ltd 1.01%
ASX ASE Technology Holding Co Ltd 0.99%
2359 HK WuXi AppTec Co Ltd 0.96%
GFNORTEO MM Grupo Financiero Banorte SAB de CV 0.96%
RIBL AB Riyad Bank 0.95%
EMBJ Embraer SA 0.94%

Top 25 holdings as of Jun 30, 2026 · source: SEC N-PORT. Full holdings & prospectus →

About EMEM

The Fund is an actively managed exchange-traded fund (“ETF”) that seeks to achieve its investment objective by investing in a diversified portfolio of equity securities issued by companies in emerging markets. Under normal circumstances, at least 80% of the Fund’s net assets (plus any borrowings for investment purposes) will be invested in equity securities of emerging market companies. “Equity securities” include listed common and preferred stock, depositary receipts (such as American Depositary Receipts (“ADRs”), Global Depositary Receipts (“GDRs”), and European Depositary Receipts (“EDRs”)), as well as ETFs that provide exposure to emerging market equities. The Fund may invest in companies of any size.An “emerging market country” is generally defined as one that (1) is included in the MSCI Emerging Market or Frontier Market indices, (2) is classified as emerging or developing by the International Finance Corporation, the World Bank, or the United Nations, or (3) has economies, industries, and stock markets with similar characteristics. An “emerging market company” is defined as one that (1) is organized under the laws of, or has its principal office in, an emerging market country, (2) derives at least 50% of its revenue from goods or services in emerging markets, or (3) has its principal securities market located in an emerging market country. The list of countries designated as emerging markets, and the Fund’s actual holdings, may change over time.The Fund’s strategy seeks to build a diversified portfolio of holdings in companies positioned for sustainable earnings growth at attractive valuations. Consilium Investment Management, dba Sophus Capital (the “Sub-Adviser”) believes that positive earnings revisions can act as catalysts for stock price appreciation. The Sub-Adviser’s investment process is designed to exploit inefficiencies in emerging markets. Specifically, the Sub-Adviser believes these markets suffer from bias, information limitations, and access constraints:•Bias: Human biases against certain countries, sectors, or companies.•Information Limitations: Variability in the quality, depth, and timing of information across markets, compounded by differing regulatory and accounting standards.•Access Constraints: Access to information can be challenging in emerging markets due to distant travel, identification of key decision makers, different management and governance models, and lack of accessibility to governments and regulators. In addition, the medium sized and smaller companies tend to have more limited research coverage, particularly in those lower in the market-cap spectrum.The Sub-Adviser employs both quantitative screening and fundamental analysis. The process begins with its proprietary Sophus Capital Emerging Markets Alpha Model (the “Model”), which ranks more than 6,000 companies across emerging markets on a scale of 1 to 100. Rankings emphasize improving earnings growth at attractive valuations, with earnings revisions and potential positive surprises as key performance drivers. Companies in the top quintile undergo further fundamental research, including analysis of financial statements, growth prospects, business strategy, value creation, competitive position, management quality, market standing, and the broader political and economic environment. The fundamental review also looks for companies that demonstrate improving fundamentals, positive earnings revisions and the ability to sustain these characteristics. The Sub-Adviser also seeks to meet annually with as many company management teams as possible to deepen its understanding of its fundamental research.The Fund is classified as “non-diversified” under the Investment Company Act of 1940, which allows it to take larger positions in fewer issuers. This increases the potential impact—positive or negative—of any single issuer’s performance on overall returns.The Sub-Adviser regularly reviews the Fund’s holdings and may sell securities when (1) a security’s rank deteriorates under the Model, (2) price appreciation reduces its attractiveness, (3) the company’s fundamental outlook changes, or (4) more compelling investment opportunities arise. As a result of its investment strategy, the Fund may experience annual portfolio turnover in excess of 100%.

EMEM News

  • No recent news found for EMEM.

Data for EMEM is aggregated from third-party providers (Tiingo, Nasdaq, Finnhub) and SEC filings, may be delayed at least 20 minutes, and may be incomplete or contain errors. Nothing here is investment advice. Verify with the official prospectus before investing.